SEngine Precision Medicine
Pre-clinicalDevelops functional precision oncology tests using patient-derived organoids to guide cancer treatment decisions.
Founded
2015
Focus
Diagnostics
About
Develops functional precision oncology tests using patient-derived organoids to guide cancer treatment decisions.
Funding History
3Total raised: $29M
Series B$15MRidgeback Capital InvestmentsJun 15, 2022
Series A$12MVulcan CapitalOct 15, 2020
Seed$2MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile